146 related articles for article (PubMed ID: 11093140)
1. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection.
Norrby-Teglund A; Chatellier S; Low DE; McGeer A; Green K; Kotb M
Eur J Immunol; 2000 Nov; 30(11):3247-55. PubMed ID: 11093140
[TBL] [Abstract][Full Text] [Related]
2. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care.
Nooh MM; Nookala S; Kansal R; Kotb M
J Immunol; 2011 Mar; 186(5):3156-63. PubMed ID: 21282506
[TBL] [Abstract][Full Text] [Related]
3. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
[TBL] [Abstract][Full Text] [Related]
4. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis.
Nooh MM; El-Gengehi N; Kansal R; David CS; Kotb M
J Immunol; 2007 Mar; 178(5):3076-83. PubMed ID: 17312154
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
Sriskandan S; Faulkner L; Hopkins P
Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
[TBL] [Abstract][Full Text] [Related]
6. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections.
Kotb M; Norrby-Teglund A; McGeer A; El-Sherbini H; Dorak MT; Khurshid A; Green K; Peeples J; Wade J; Thomson G; Schwartz B; Low DE
Nat Med; 2002 Dec; 8(12):1398-404. PubMed ID: 12436116
[TBL] [Abstract][Full Text] [Related]
7. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
Basma H; Norrby-Teglund A; Guedez Y; McGeer A; Low DE; El-Ahmedy O; Schwartz B; Kotb M
Infect Immun; 1999 Apr; 67(4):1871-7. PubMed ID: 10085030
[TBL] [Abstract][Full Text] [Related]
8. Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience.
Kotb M; Norrby-Teglund A; McGeer A; Green K; Low DE
Scand J Infect Dis; 2003; 35(9):665-9. PubMed ID: 14620152
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates.
Norrby-Teglund A; Lustig R; Kotb M
Infect Immun; 1997 Dec; 65(12):5209-15. PubMed ID: 9393817
[TBL] [Abstract][Full Text] [Related]
10. MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome.
Emgård J; Bergsten H; McCormick JK; Barrantes I; Skrede S; Sandberg JK; Norrby-Teglund A
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25923-25931. PubMed ID: 31772015
[TBL] [Abstract][Full Text] [Related]
11. Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity.
Yang LP; Eriksson BK; Harrington Z; Curtis N; Lang S; Currie BJ; Fraser JD; Proft T
Med Microbiol Immunol; 2006 Mar; 195(1):37-43. PubMed ID: 15988608
[TBL] [Abstract][Full Text] [Related]
12. The cytokine response to streptococcal superantigens varies between individual toxins and between individuals: implications for the pathogenesis of group A streptococcal diseases.
Proft T; Schrage B; Fraser JD
J Interferon Cytokine Res; 2007 Jul; 27(7):553-7. PubMed ID: 17651016
[TBL] [Abstract][Full Text] [Related]
13. Evidence for superantigen involvement in severe group a streptococcal tissue infections.
Norrby-Teglund A; Thulin P; Gan BS; Kotb M; McGeer A; Andersson J; Low DE
J Infect Dis; 2001 Oct; 184(7):853-60. PubMed ID: 11509997
[TBL] [Abstract][Full Text] [Related]
14. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
[TBL] [Abstract][Full Text] [Related]
15. Hyporesponsiveness of peripheral blood lymphocytes to streptococcal superantigens in patients with guttate psoriasis: evidence for systemic stimulation of T cells with superantigens released from focally infecting Streptococcus pyogenes.
Tokura Y; Seo N; Ohshima A; Wakita H; Yokote R; Furukawa F; Takigawa M
Arch Dermatol Res; 1999; 291(7-8):382-9. PubMed ID: 10482006
[TBL] [Abstract][Full Text] [Related]
16. Systemic cytokine response in moribund mice of streptococcal toxic shock syndrome model.
Saito M; Kajiwara H; Iida K; Hoshina T; Kusuhara K; Hara T; Yoshida S
Microb Pathog; 2011 Feb; 50(2):109-13. PubMed ID: 21146602
[TBL] [Abstract][Full Text] [Related]
17. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
Norrby-Teglund A; Nepom GT; Kotb M
Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
[TBL] [Abstract][Full Text] [Related]
18. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.
Reglinski M; Sriskandan S
Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731
[TBL] [Abstract][Full Text] [Related]
19. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
